These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 33620751)

  • 21. Family history of cancer and colon cancer risk: the Utah Population Database.
    Slattery ML; Kerber RA
    J Natl Cancer Inst; 1994 Nov; 86(21):1618-26. PubMed ID: 7932826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mammographic screening in women with a family history of breast cancer: some results from the Swedish two-county trial.
    Nixon RM; Pharoah P; Tabar L; Krusemo UB; Duffy SW; Prevost TC; Chen HH
    Rev Epidemiol Sante Publique; 2000 Aug; 48(4):325-31. PubMed ID: 11011299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Family history of breast, ovarian and endometrial cancer and risk of breast cancer.
    Parazzini F; La Vecchia C; Negri E; Franceschi S; Tozzi L
    Int J Epidemiol; 1993 Aug; 22(4):614-8. PubMed ID: 8225733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. First-degree family history of prostate cancer is associated the risk of breast cancer and ovarian cancer.
    Zheng Q; Ying Q; Ren Z; Zhang Q; Lu D; Wang H; Wei W
    Medicine (Baltimore); 2021 Jan; 100(4):e23816. PubMed ID: 33530178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of family history on ovarian cancer risk. The Utah Population Database.
    Kerber RA; Slattery ML
    Arch Intern Med; 1995 May; 155(9):905-12. PubMed ID: 7726698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening of over 1000 Indian patients with breast and/or ovarian cancer with a multi-gene panel: prevalence of BRCA1/2 and non-BRCA mutations.
    Singh J; Thota N; Singh S; Padhi S; Mohan P; Deshwal S; Sur S; Ghosh M; Agarwal A; Sarin R; Ahmed R; Almel S; Chakraborti B; Raina V; DadiReddy PK; Smruti BK; Rajappa S; Dodagoudar C; Aggarwal S; Singhal M; Joshi A; Kumar R; Kumar A; Mishra DK; Arora N; Karaba A; Sankaran S; Katragadda S; Ghosh A; Veeramachaneni V; Hariharan R; Mannan AU
    Breast Cancer Res Treat; 2018 Jul; 170(1):189-196. PubMed ID: 29470806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study.
    Zahl PH; Gøtzsche PC; Mæhlen J
    Lancet Oncol; 2011 Nov; 12(12):1118-24. PubMed ID: 21996169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mammographic surveillance in women younger than 50 years who have a family history of breast cancer: tumour characteristics and projected effect on mortality in the prospective, single-arm, FH01 study.
    FH01 collaborative teams
    Lancet Oncol; 2010 Dec; 11(12):1127-34. PubMed ID: 21093374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer screening and risk-reducing behaviors of women seeking genetic cancer risk assessment for breast and ovarian cancers.
    MacDonald DJ; Sarna L; Uman GC; Grant M; Weitzel JN
    Oncol Nurs Forum; 2006 Nov; 33(2):E27-35. PubMed ID: 16518435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk - Combined Results from Two Screening Trials.
    Skates SJ; Greene MH; Buys SS; Mai PL; Brown P; Piedmonte M; Rodriguez G; Schorge JO; Sherman M; Daly MB; Rutherford T; Brewster WR; O'Malley DM; Partridge E; Boggess J; Drescher CW; Isaacs C; Berchuck A; Domchek S; Davidson SA; Edwards R; Elg SA; Wakeley K; Phillips KA; Armstrong D; Horowitz I; Fabian CJ; Walker J; Sluss PM; Welch W; Minasian L; Horick NK; Kasten CH; Nayfield S; Alberts D; Finkelstein DM; Lu KH
    Clin Cancer Res; 2017 Jul; 23(14):3628-3637. PubMed ID: 28143870
    [No Abstract]   [Full Text] [Related]  

  • 31. Factors associated with the incompliance with mammogram screening among individuals with a family history of breast cancer or ovarian cancer.
    Wu H; Zhu K; Jatoi I; Shah M; Shriver CD; Potter J
    Breast Cancer Res Treat; 2007 Mar; 101(3):317-24. PubMed ID: 16821080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ovarian cancer screening in women with a family history of breast or ovarian cancer.
    Lacey JV; Greene MH; Buys SS; Reding D; Riley TL; Berg CD; Fagerstrom RM; Hartge P
    Obstet Gynecol; 2006 Nov; 108(5):1176-84. PubMed ID: 17077240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screen-positive rates and agreement among six family history screening protocols for breast/ovarian cancer in a population-based cohort of 21- to 55-year-old women.
    Palomaki GE; McClain MR; Steinort K; Sifri R; LoPresti L; Haddow JE
    Genet Med; 2006 Mar; 8(3):161-8. PubMed ID: 16540750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer.
    Loman N; Johannsson O; Kristoffersson U; Olsson H; Borg A
    J Natl Cancer Inst; 2001 Aug; 93(16):1215-23. PubMed ID: 11504767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aggregation of ovarian cancer with breast, ovarian, colorectal, and prostate cancer in first-degree relatives.
    Tung KH; Goodman MT; Wu AH; McDuffie K; Wilkens LR; Nomura AM; Kolonel LN
    Am J Epidemiol; 2004 Apr; 159(8):750-8. PubMed ID: 15051584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Population-based screening for hereditary breast cancer in a region of North-Central Italy.
    Casadei S; Falcini F; Naldoni C; Amadori D; Calistri D
    Int J Mol Med; 2002 Sep; 10(3):299-305. PubMed ID: 12165804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Age of onset in familial breast cancer as background data for medical surveillance.
    Brandt A; Bermejo JL; Sundquist J; Hemminki K
    Br J Cancer; 2010 Jan; 102(1):42-7. PubMed ID: 19904271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ovarian and breast cancer risks to women in families with two or more cases of ovarian cancer.
    Sutcliffe S; Pharoah PD; Easton DF; Ponder BA
    Int J Cancer; 2000 Jul; 87(1):110-7. PubMed ID: 10861460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of cancer at sites other than the breast in Swedish families eligible for BRCA1 or BRCA2 mutation testing.
    Lorenzo Bermejo J; Hemminki K
    Ann Oncol; 2004 Dec; 15(12):1834-41. PubMed ID: 15550590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Population prevalence of first- and second-degree family history of breast and ovarian cancer.
    Moghimi-Dehkordi B; Safaee A; Vahedi M; Pourhoseingholi MA; Pourhoseingholi A; Zali MR
    East Afr J Public Health; 2011 Dec; 8(4):275-7. PubMed ID: 23120936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.